This is a leprosy quiz…. Firstly explain all the answers and later prepare more questions of leprosy with explanation for a quiz also add a section on recent advances or currents in leprosy

Reading File
Reading File
Finding Sources
Searching PubMed

leprosy AND treatment

Searching the Web

WHO leprosy current updates 2025 post-exposure prophylaxis treatment guidelines

Browsing Directory

~/

Reading File
Finding Sources
Reading File
Running Command

python -c "from pypdf import PdfReader; p='/tmp/workspace/attachments/94219519-653d-41e8-b82d-da398d2487d5/Leprosy quiz.pdf'; r=PdfReader(p); print('PAGES',len(r.pages)); [print('\\n--- PAGE %d ---\\n%s'%(i+1,(x.extract_text() or ''))) for i,x in enumerate(r.pages)]"

Reading File
Reading File
Searching the Web

"Leprosy Quiz" "Poppy seeds on muffin"

Reading Web Page

https://www.who.int/news-room/fact-sheets/detail/leprosy

Reading Web Page

https://ijpgderma.org/leprosy-quiz

Finding Sources
Reading Article

PMID: 41082563

Reading Article

PMID: 39632641

Leprosy quiz: answers explained

The answers below follow the key in the supplied 2024 Leprosy Quiz. A few questions use older epidemiological figures or examination conventions, which I flag where relevant.
  1. b) Kellgren and Lawrence
    This is a radiological grading system for osteoarthritis, not a leprosy classification. Manila, Pan-American, and Havana are historical leprosy classification systems.
  2. a) USG nerve finding
    “Poppy seeds on a muffin” describes the transverse ultrasonographic appearance of a nerve: multiple hypoechoic fascicles surrounded by echogenic epineurium. It is useful when evaluating nerve enlargement in leprosy.
  3. b) 5 mm²
    The usual mean cross-sectional area of a normal ulnar nerve at the cubital tunnel is approximately 5 mm². The question prints “mm,” but cross-sectional area should be expressed as mm². Enlargement supports neuritis, though measurements must be compared with the opposite side and interpreted clinically.
  4. d) None of the above
    In WHO disability grading, eye grade 1 refers to an eye problem attributable to leprosy, but without severe visual impairment. Inability to close the eye and visible corneal or ocular complications are generally graded as more serious disability. A visual acuity threshold of 6/18 is not the stated grade-1 criterion in this question.
  5. d) BCL10
    HLA associations and variants such as PTPN22 have been studied as host-susceptibility factors in leprosy. BCL10 is not a standard established association in the classic leprosy predisposition lists used for examinations.
  6. c) Sweating
    Early involvement of autonomic fibers can reduce sweating over a lesion. The patch can become dry before sensory loss becomes obvious. In clinical examination, test sensation carefully, especially light touch, pain, and temperature.
  7. a) BT Hansen disease
    A “feeding nerve” entering a lesion is especially associated with borderline tuberculoid (BT) leprosy. It reflects localized neural involvement, often near a well-defined, anesthetic lesion.
  8. b) 6 blinks/minute
    This is the quiz key and reflects the examination convention used for assessing facial nerve function in leprosy. In general physiology, spontaneous blink rate varies substantially and is often quoted higher than 6/minute. For this quiz, use 6/minute.
  9. a) Median nerve
    The benediction sign appears when a patient with a median nerve palsy tries to make a fist: the index and middle fingers cannot flex properly. It should not be confused with ulnar clawing, which is evident at rest and mainly affects the ring and little fingers.
  10. b) Nasal mucosa is usually involved
    This is incorrect. Histoid leprosy, first described by Wade, presents with shiny papules or nodules, sometimes subcutaneous lesions, typically with abundant bacilli. Eyebrows are often preserved. Nasal mucosal involvement is not usual.
  11. b) 46 days
    Lepra bacilli can survive for about 46 days in moist soil in experimental observations. This demonstrates environmental survival, but ordinary environmental contact is not considered the principal route of transmission.
  12. a) 1-10 solid bacilli
    In the mouse footpad model, a very small inoculum of about 1-10 viable solid-staining bacilli may establish infection. M. leprae cannot be routinely cultured in artificial media, making animal models historically important.
  13. d) Ethmoidal sinus
    The ethmoidal sinus is the most commonly involved paranasal sinus in leprosy. This is more relevant in multibacillary disease, where nasal involvement can occur.
  14. c) 11-14 days
    Mycobacterium leprae has a slow generation time of approximately 11-14 days, helping explain the long incubation period and indolent course of disease.
  15. a) 7-9 days
    Lepra bacilli can survive in dried nasal secretions for 7-9 days under experimental conditions. Transmission in practice is mainly linked to prolonged, close exposure to an untreated infectious case.
  16. b) 0.45 per 10,000 population
    This is the answer in the 2024 source quiz and reflects the figure used by its author at that time. It should not be treated as a fixed current figure for India because annual prevalence changes with surveillance and reporting. In an examination, answer 0.45 for this specific published quiz.
  17. d) Delhi
    MIP, now known as Mycobacterium indicus pranii, was developed in Delhi, associated with work at the National Institute of Immunology. It has been studied as an immunotherapeutic adjunct and in vaccine-related approaches.
  18. c) 6 mg/kg
    The monthly supervised dose of clofazimine in childhood leprosy is 6 mg/kg. Pediatric regimens must follow national or WHO weight-band guidance and maximum-dose limits.
  19. a) Rifampicin, clofazimine, and dapsone for 6 months
    WHO recommends a three-drug MDT regimen for paucibacillary disease for 6 months. This uniform regimen includes clofazimine, unlike older PB regimens that used rifampicin plus dapsone only. The WHO leprosy guidance continues to state 6 months for PB and 12 months for MB disease.
  20. a) Fitness of the hand for reconstructive surgery
    Bouvier’s manoeuvre helps assess whether passive correction of clawing permits active extension at the interphalangeal joints. It therefore helps decide suitability and select the type of tendon-transfer reconstruction for ulnar palsy.

Additional leprosy quiz questions

1. Which is a cardinal sign of leprosy?

a) Itching in every skin lesion
b) Definite sensory loss in a hypopigmented or erythematous patch
c) Generalized fever
d) Hair loss alone
Answer: b) Definite sensory loss in a hypopigmented or erythematous patch
WHO diagnosis is clinical when at least one cardinal sign is present: definite sensory loss in a lesion, thickened peripheral nerve with sensory or motor deficit, or acid-fast bacilli on slit-skin smear.

2. Which nerve is commonly palpated behind the medial epicondyle in leprosy?

a) Radial nerve
b) Ulnar nerve
c) Median nerve
d) Common peroneal nerve
Answer: b) Ulnar nerve
The ulnar nerve is palpated in the ulnar groove behind the medial epicondyle. Tenderness, thickening, and impaired function suggest neuritis.

3. A patient has one anesthetic plaque, asymmetrical nerve thickening, and a negative slit-skin smear. The likely end of the spectrum is:

a) Lepromatous leprosy
b) Tuberculoid leprosy
c) Histoid leprosy
d) Lucio phenomenon
Answer: b) Tuberculoid leprosy
Tuberculoid disease has strong cell-mediated immunity, few bacilli, localized lesions, and asymmetrical nerve involvement. In contrast, lepromatous disease is generally widespread and highly bacillated.

4. Which immune response predominates in tuberculoid leprosy?

a) Predominantly Th1 cell-mediated response
b) Predominantly Th2 humoral response
c) Complete absence of macrophage activation
d) Neutrophil-only response
Answer: a) Predominantly Th1 cell-mediated response
A Th1 response with interferon-gamma activates macrophages and restricts bacterial multiplication. This accounts for the low bacillary burden in tuberculoid disease.

5. Which immune pattern is more typical of lepromatous leprosy?

a) Strong Th1 response with few bacilli
b) Weak cell-mediated immunity and heavy bacillary load
c) No nerve involvement
d) A single sharply defined plaque only
Answer: b) Weak cell-mediated immunity and heavy bacillary load
Lepromatous leprosy is characterized by poor cell-mediated control, numerous bacilli in macrophages and Schwann cells, and more symmetrical, widespread disease.

6. Type 1 lepra reaction is also called:

a) Erythema nodosum leprosum
b) Reversal reaction
c) Lucio reaction
d) Jarisch-Herxheimer reaction
Answer: b) Reversal reaction
Type 1 reaction is an acute increase in cell-mediated immunity, typically in borderline forms of leprosy. Existing lesions become inflamed and swollen, and neuritis may cause acute nerve-function impairment.

7. Erythema nodosum leprosum is most closely associated with:

a) Paucibacillary disease only
b) Multibacillary disease
c) Tuberculoid disease only
d) Indeterminate disease only
Answer: b) Multibacillary disease
ENL is a type 2 immune-complex-mediated reaction, usually occurring in BL or LL disease. Tender nodules may be accompanied by fever, arthritis, neuritis, orchitis, iridocyclitis, and systemic illness.

8. A new foot drop in leprosy should be treated as:

a) A cosmetic issue only
b) An emergency requiring assessment for neuritis and prompt treatment
c) Proof of completed cure
d) An indication to stop MDT immediately
Answer: b) An emergency requiring assessment for neuritis and prompt treatment
New motor weakness indicates nerve-function impairment. Delay can lead to irreversible disability. Urgent specialist evaluation and anti-inflammatory treatment are needed while antimicrobial MDT is continued as indicated.

9. The main route of transmission of leprosy is thought to be:

a) Casual touch and sharing food
b) Mosquito bites
c) Respiratory droplets during prolonged close contact with an untreated case
d) Transmission only through skin ulcers
Answer: c) Respiratory droplets during prolonged close contact with an untreated case
Leprosy is not spread by casual contact such as handshaking, hugging, sharing meals, or sitting together. WHO notes that infectiousness stops after effective MDT begins.

10. Which is the standard MDT duration for multibacillary leprosy in WHO guidance?

a) 1 month
b) 6 months
c) 12 months
d) 24 months for every patient
Answer: c) 12 months
The WHO regimen uses rifampicin, dapsone, and clofazimine for 12 months in MB disease.

11. Which drug is responsible for characteristic skin discoloration during MDT?

a) Rifampicin
b) Dapsone
c) Clofazimine
d) Pyridoxine
Answer: c) Clofazimine
Clofazimine can cause red-brown to blackish skin discoloration and dryness. Explaining this effect before treatment helps adherence.

12. A slit-skin smear is most useful for:

a) Confirming a multibacillary infection and assessing bacillary load
b) Measuring nerve conduction velocity
c) Diagnosing all anesthetic patches with certainty
d) Identifying fungal hyphae
Answer: a) Confirming a multibacillary infection and assessing bacillary load
Smear positivity is a cardinal diagnostic sign and supports multibacillary classification. A negative smear does not exclude PB leprosy.

13. Which finding best distinguishes relapse from a lepra reaction?

a) All relapse occurs within one week
b) Relapse is usually gradual, whereas reactions are often acute and inflammatory
c) Reactions never affect nerves
d) Relapse always has fever
Answer: b) Relapse is usually gradual, whereas reactions are often acute and inflammatory
Relapse often presents with gradual reappearance or increase in lesions and bacterial activity after treatment. Reactions are abrupt inflammatory episodes and may occur during or after MDT.

14. What is the most important measure to prevent disability?

a) Waiting for lesions to resolve naturally
b) Early diagnosis, complete MDT, and regular nerve-function assessment
c) Avoiding all physical activity
d) Isolating every treated patient indefinitely
Answer: b) Early diagnosis, complete MDT, and regular nerve-function assessment
Disability prevention depends on early cure, rapid recognition of neuritis or reactions, protective self-care for anesthetic hands and feet, and rehabilitation when needed.

15. Which statement about leprosy after treatment is correct?

a) Patients remain infectious for years despite MDT
b) Effective treatment stops transmission
c) Every patient needs lifelong isolation
d) MDT cannot prevent disability
Answer: b) Effective treatment stops transmission
Leprosy is curable. Prompt MDT kills the organism and prevents ongoing transmission, although existing nerve damage may not fully reverse.

Recent advances and current issues in leprosy

1. Uniform three-drug MDT

The current WHO approach uses rifampicin, dapsone, and clofazimine for both classifications: 6 months for PB and 12 months for MB disease. This replaced older PB regimens that omitted clofazimine. See the WHO treatment summary.

2. Contact screening plus single-dose rifampicin PEP

Treatment of detected cases alone does not fully interrupt transmission. WHO recommends screening household, neighbourhood, and social contacts, accompanied where appropriate by single-dose rifampicin post-exposure prophylaxis, or SDR-PEP. This is a major current prevention strategy.

3. Zero leprosy strategy, 2021-2030

WHO’s present strategy aims for:
  • Zero infection and disease
  • Zero disability
  • Zero stigma and discrimination
  • Integrated skin-NTD services, early case detection, contact tracing, disability prevention, and rights-based care.

4. Earlier detection of subclinical infection

Research is focused on molecular tests such as PCR for M. leprae, serological markers including anti-PGL-I antibodies, and combinations of clinical, molecular, and immune markers. These are promising but are not yet replacements for clinical examination in routine field practice.

5. Ultrasound for peripheral nerve assessment

High-resolution nerve ultrasonography can show nerve enlargement, altered fascicular pattern, and increased vascularity in neuritis. It can support diagnosis and monitor inflammatory neuropathy, especially when clinical findings are uncertain.

6. Drug-resistance surveillance

Molecular testing for resistance-associated mutations, particularly involving rifampicin, dapsone, and fluoroquinolones, is increasingly important in suspected relapse, treatment failure, or exposure to previous treatment. This allows more rational use of alternative regimens.

7. Vaccines and immunotherapy remain active research areas

BCG provides partial protection, and MIP or Mycobacterium indicus pranii has been investigated as an immunotherapeutic or preventive tool. A 2024 systematic review found a signal of benefit from available vaccine studies, but heterogeneity and differences between interventions mean that a universally adopted new leprosy vaccine has not yet replaced current control measures. See the 2024 vaccine meta-analysis.

8. Relapse requires long-term vigilance

A 2025 systematic review and meta-analysis found a pooled relapse estimate of about 4%, with greater risk among multibacillary cases, people with high bacillary load, established disability, and some demographic groups. This reinforces the importance of differentiating relapse from reactions and maintaining follow-up where clinically indicated. See the relapse review.

9. Stigma, mental health, and disability care are central

Current care goes beyond antibiotics: it includes prevention of ulcers and injuries, eye and hand-foot protection, physiotherapy, reconstructive surgery when appropriate, socioeconomic inclusion, and active work against discrimination.

U missed 1 question before bcl10 ques- Which of the following is considered as the grade 1 disability for eyes based on the World Health Organization grading of disabilities in leprosy? a) Inability to close the eyes b) Obvious redness of eyes c) Visual impairment of 6/18 d) None of the above

Reading File
Finding Sources
Searching the Web

WHO leprosy disability grading eye grade 1 inability close eye redness visual acuity 6/18

Searching PubMed

leprosy disability

You are right to highlight it. I included it, but my explanation was incorrect.

Correct answer: c) Visual impairment of 6/18

Under the WHO grading for eye disability in leprosy:
  • Grade 0: No eye problem due to leprosy and no visual impairment.
  • Grade 1: Eye involvement due to leprosy without severe visual loss. Visual acuity of 6/18 is included here.
  • Grade 2: Severe ocular disability, such as:
    • Lagophthalmos or inability to close the eye
    • Corneal opacity or corneal ulcer
    • Iridocyclitis
    • Severe visual loss, typically worse than 6/60 or inability to count fingers at 6 metres.
Therefore:
  • a) Inability to close the eyes: Grade 2
  • b) Obvious redness of eyes: generally treated as a serious visible eye complication in simplified field grading, not the expected Grade 1 answer here
  • c) Visual impairment of 6/18: Grade 1
  • d) None of the above: incorrect
The distinction is supported by the WHO definition: grade 1 means eye problems due to leprosy with vision not severely affected, namely visual acuity 6/60 or better. Thus, 6/18 falls in Grade 1. Harrison’s Principles of Internal Medicine similarly states that grade 1 denotes leprosy-related eye problems without severe visual effect, whereas lagophthalmos is Grade 2.

They say answer is d and who grading is this- WHO Eye Disability GradesGrade 0: No eye problem due to leprosy; no evidence of visual loss.Grade 1: Eye problems due to leprosy present, but vision is not severely affected (visual acuity is 6/60 or better; the person can count fingers at 6 meters).Grade 2: Severe visual impairment (vision worse than 6/60; inability to count fingers at 6 meters), and/or visible deformities/damage such as:Lagophthalmos (inability to close the eyelids completely)Iridocyclitis / uveitis (inflammation of the iris or middle layer of the eye)Corneal opacities or damag

Reading File
Searching the Web

WHO leprosy disability grading grade 1 eyes visual impairment 6/18 red eye lagophthalmos operational definitions

Finding Sources
Searching PubMed

leprosy eye disability

Yes. The grading system you quoted is the WHO 3-grade disability system for leprosy, and it is correct:
Eye gradeWHO definition
Grade 0No eye problem due to leprosy and no visual loss
Grade 1Eye problem due to leprosy, but vision not severely affected: vision 6/60 or better or can count fingers at 6 m
Grade 2Vision worse than 6/60 or cannot count fingers at 6 m, and/or lagophthalmos, iridocyclitis, or corneal opacity
So, the quiz key’s answer, d) None of the above, is defensible only under a strict reading of the wording:
  • a) Inability to close the eyes = lagophthalmos = Grade 2
  • b) Obvious redness of eyes = a concerning ocular sign, but it is not by itself the standard defining criterion for WHO Grade 1 in the simplified WHO disability grade
  • c) Visual impairment of 6/18 = this is not automatically Grade 1 unless the visual impairment is specifically shown to be due to leprosy. Visual acuity alone does not establish that.
Therefore, in the exact MCQ wording, none of the options explicitly says “an eye problem due to leprosy with vision 6/60 or better.” Hence their intended answer is d.
However, the question is poorly framed, because 6/18 is numerically within the “6/60 or better” range. Older WHO operational descriptions give examples of Grade 1 that include visual acuity levels such as 6/18, 6/24, 6/36, or 6/60 when the reduction is due to leprosy. The missing phrase “due to leprosy” is what changes the answer.

Best exam explanation

Answer: d) None of the above
Grade 1 eye disability requires an eye problem attributable to leprosy with no severe visual impairment.
  • Lagophthalmos is Grade 2.
  • A red eye alone is not the defining Grade 1 criterion.
  • Visual acuity of 6/18 can only be classified as Grade 1 if the visual loss is confirmed to be due to leprosy. Since the option does not state this, the intended answer is none of the above.
My earlier statement that c was definitely correct was too categorical. The supplied quiz’s key answers d, and the wording supports that intended answer.
This is a shared conversation. Sign in to Orris to start your own chat.